Nyaderm · DIN 00716871 · 100000U/g · Cr
General benefitMarketed · checked November 18, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
1 brand, same coverage
Nyaderm · DIN 00716871
Manufacturer: Taro Pharmaceuticals Inc.; listing date 1996-10-01
Health Canada: Marketed since 1979-12-31 · brand NYADERM · ATC D01AA01 NYSTATIN · form Cream · route Topical · ingredients NYSTATIN 100000 UNIT/G · company Space age brands · schedule Non-prescription drugs
Nyaderm: Formulary list price $0.20 per unit (the source does not state the unit; exact figure $0.2037). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 00716871)
Source record
DIN 00716871: Nyaderm
Raw flags: sec3=Y
Item: 840408004; group id 823; item number 2005; lccId None; manufacturer id TAR
Source form: Cr; strength: 100000U/g
Recorded listing: General benefit
Source prices (unrounded): $0.2037; ministry $0.2037
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00716871
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=8977
Therapeutic Notes (formulary)
Nystatin is not effective in the treatment of Dermatophyte infections or Tinea versicolor.
Interchangeable products
Mycostatin · DIN 00029092 · not recorded
Shortage status: not checked (no credentials)